|
Index of reports
> Cases resulting in life threatening events (27)
> Cases with Pulmonary Hypertension (4)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in life threatening events where reactions include pulmonary hypertension.
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Dizziness
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
Efavirenz
Dosage: therapy stopped on 25-jul-2000, restarted on 25-sep-2000.
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-10-02
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2001-10-20
Indinivir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-08
End date: 2000-05-24
Ziagen
Dosage: therapy stopped on 25-jul-2000, restarted on 20-oct-2001.
Administration route: Oral
Start date: 2000-07-24
End date: 2001-10-27
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
Ritonavir
Dosage: therapy stopped on 24-dec-2000, restarted on 01-apr-2005.
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Lopinavir + Ritonavir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Other drugs received by patient: Factor Viii
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-05
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea, Palpitations, Asthenia, Pulmonary Artery Dilatation, Cardiomegaly
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
Norvir
Administration route: Oral
Start date: 2004-04-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Stocrin
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 2001-07-21
Zerit
Administration route: Oral
Start date: 1997-08-25
End date: 2001-10-20
Crixivan
Dosage: 800mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Invirase
Dosage: 800mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Other drugs received by patient: Reyataz; Viread; Anti-Hemophilic Globulin; Ziagen
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-05-09
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dizziness
Adverse event resulted in: life threatening event
Suspect drug(s):
Crixivan
Dosage: 800 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Efavirenz
Dosage: 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Efavirenz
Dosage: 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-09-25
End date: 2000-10-02
Didanosine
Dosage: 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
CAP Stavudine
Dosage: 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
TAB [therapy Unspecified]
Dosage: 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
CAP Saquinavir Mesylate
Dosage: see image
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-03-18
CAP Saquinavir Mesylate
Dosage: see image
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-03-18
CAP Saquinavir Mesylate
Dosage: see image
Indication: HIV Infection
Start date: 2000-05-24
CAP Ritonavir
Dosage: see image
Indication: HIV Infection
Start date: 1999-06-19
End date: 1999-10-31
CAP Ritonavir
Dosage: see image
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
CAP Ritonavir
Dosage: see image
Indication: HIV Infection
Start date: 2005-04-01
Videx
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 1997-03-07
Videx
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 1997-03-08
End date: 2001-07-21
Videx EC
Dosage: 400 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-22
End date: 2004-05-14
Ziagen
Dosage: 600 mg/daily po
Administration route: Oral
Start date: 2000-07-24
End date: 2000-07-25
Ziagen
Dosage: 600 mg/daily po
Administration route: Oral
Start date: 2001-10-20
End date: 2001-10-27
Kaletra
Dosage: 6 dose/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Epivir
Dosage: 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Other drugs received by patient: Factor Viii
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-03-16
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea
Adverse event resulted in: life threatening event
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
Norvir
Administration route: Oral
Start date: 2004-04-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Stocrin
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Other drugs received by patient: Reyataz; Viread; Cross Eight M
|
